RETRACTED: Influence of miR-376c-3p/SYF2 Axis on the Progression of Gastric Cancer (Retracted Article)

被引：0
|
作者：
Liu, Bin [1 ]
Li, Guangchun [1 ]
Zhang, Zhen [1 ]
Wu, Honglei [1 ]
机构：
[1] Shandong Univ, Hosp 2, Dept Gastroenterol, 247 Beiyuan St, Jinan 250033, Shandong, Peoples R China
来源：
TECHNOLOGY IN CANCER RESEARCH & TREATMENT | 2019年 / 18卷
关键词：
miR-376c-3p; SYF2; gastric cancer; tumor suppressor; cell behaviors; SYF2; PROLIFERATION; METASTASIS; PROGNOSIS; CYCLE;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MicroRNA-376c-3p was previous reported to have a crucial role in the progression of human cancer. This study was aimed to investigate the influence of microRNA-376c-3p on the proliferation and migration of human gastric cancer cells and the associated mechanism. We explored the expression of microRNA-376c-3p in gastric cancer cells using reverse transcription-quantitative polymerase chain reaction. Also, we analyzed the association and biological significance of microRNA-376c-3p and SYF2 pre-mRNA-splicing factor in gastric cancer. MicroRNA-376c-3p expression was found downregulated in gastric cancer cell lines compared to the normal cell line. MicroRNA-376c-3p directly targeted SYF2 and reduced SYF2 expression. Overexpression of microRNA-376c-3p inhibits gastric cancer cell proliferation and migration. Besides that, overexpression of SYF2 abrogates the inhibitory influences on gastric cancer cell behaviors caused by microRNA-376c-3p mimic. These results showed that microRNA-376c-3p inhibits the proliferation and migration of gastric cancer cells via targeting SYF2.
引用
收藏
页数：6
相关论文
共 50 条
  • [1] RETRACTION: Influence of miR-376c-3p/SYF2 Axis on the Progression of Gastric Cancer (Retraction of September, 10.1177/1533033819874808, 2019)
    Liu, B.
    Li, G.
    Zhang, Z.
    Wu, H.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
  • [2] RETRACTION: Influence of miR-376c-3p/SYF2 Axis on the Progression of Gastric Cancer (Retraction of Vol 18, art no 1533033819874808, 2019)
    Liu, Bin
    Li, Guangchun
    Zhang, Zhen
    Wu, Honglei
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
  • [3] CircPIP5K1A facilitates gastric cancer progression via miR-376c-3p/ZNF146 axis
    Ma, Yan
    Cong, Xiliang
    Zhang, Yiyun
    Yin, Xin
    Zhu, Ziyu
    Xue, Yingwei
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [4] CircPIP5K1A facilitates gastric cancer progression via miR-376c-3p/ZNF146 axis
    Yan Ma
    Xiliang Cong
    Yiyun Zhang
    Xin Yin
    Ziyu Zhu
    Yingwei Xue
    Cancer Cell International, 20
  • [5] RETRACTED: Circular RNA PTK2 modifies the progression and radiosensitivity in gastric cancer via miR-369-3p/ZEB1 axis (Retracted Article)
    Liu, Yuqiang
    Yao, Kun
    Zhang, Ke
    Wang, Jianping
    Dai, Qiang
    Wang, Rong
    RSC ADVANCES, 2020, 10 (03) : 1711 - 1723
  • [6] RETRACTED: miR-152-3p Affects the Progression of Colon Cancer via the KLF4/IFITM3 Axis (Retracted Article)
    Zhu, Xiaoyi
    Shen, Zhan
    Man, Da
    Ruan, Hang
    Huang, Sha
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2020, 2020
  • [7] RETRACTED: LOXL1-AS1 Drives The Progression Of Gastric Cancer Via Regulating miR-142-5p/PIK3CA Axis (Retracted Article)
    Li, Ming
    Cai, Ou
    Tan, Shiyun
    ONCOTARGETS AND THERAPY, 2019, 12 : 11345 - 11357
  • [8] RETRACTED: KCNQ1OT1 accelerates gastric cancer progression via miR-4319/DRAM2 axis (Retracted Article)
    Wang, Jijun
    Wu, Fan
    Li, Yaoyao
    Pang, Lei
    Wang, Xiaohong
    Kong, Guimei
    Zhang, Tong
    Yu, Duonan
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2020, 34
  • [9] RETRACTED: lncRNA CRNDE is Upregulated in Glioblastoma Multiforme and Facilitates Cancer Progression Through Targeting miR-337-3p and ELMOD2 Axis (Retracted Article)
    Gao, Jian
    Chen, Qunbang
    Zhao, Yingjia
    Hou, Ruizhe
    ONCOTARGETS AND THERAPY, 2020, 13 : 9225 - 9234
  • [10] RETRACTED: Low Expression of miR-491-3p Is Correlated with Lymph Node Metastasis in Gastric Cancer (Retracted Article)
    Yu, Haiou
    Luo, Shuang
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
12345